Nucleic Vaccine Market, Global Outlook and Forecast 2022-2028
A nucleic vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.
This report contains market size and forecasts of Nucleic Vaccine in global, including the following market information:
Global Nucleic Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nucleic Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nucleic Vaccine companies in 2021 (%)
The global Nucleic Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Preventive Nucleic Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nucleic Vaccine include Moderna, CureVac, Inovio, Sanofi, GSK, CNBG, Hualan Bio, Zhifei Shengwu and Liaoning Chengda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nucleic Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nucleic Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Nucleic Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Nucleic Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Nucleic Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nucleic Vaccine revenues share in global market, 2021 (%)
Key companies Nucleic Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nucleic Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Nucleic Vaccine in global, including the following market information:
Global Nucleic Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nucleic Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Nucleic Vaccine companies in 2021 (%)
The global Nucleic Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Preventive Nucleic Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nucleic Vaccine include Moderna, CureVac, Inovio, Sanofi, GSK, CNBG, Hualan Bio, Zhifei Shengwu and Liaoning Chengda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nucleic Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Nucleic Vaccine Market Segment Percentages, by Type, 2021 (%)
- Preventive Nucleic Vaccine
- Therapeutic Nucleic Vaccine
Global Nucleic Vaccine Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinic
- Others
Global Nucleic Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Nucleic Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nucleic Vaccine revenues share in global market, 2021 (%)
Key companies Nucleic Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Nucleic Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Moderna
- CureVac
- Inovio
- Sanofi
- GSK
- CNBG
- Hualan Bio
- Zhifei Shengwu
- Liaoning Chengda
- BioKangtai
- CanSinoBIO
- Walvax Biotechnology
- Fosun Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Nucleic Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NUCLEIC VACCINE OVERALL MARKET SIZE
2.1 Global Nucleic Vaccine Market Size: 2021 VS 2028
2.2 Global Nucleic Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nucleic Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Nucleic Vaccine Players in Global Market
3.2 Top Global Nucleic Vaccine Companies Ranked by Revenue
3.3 Global Nucleic Vaccine Revenue by Companies
3.4 Global Nucleic Vaccine Sales by Companies
3.5 Global Nucleic Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nucleic Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nucleic Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nucleic Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Nucleic Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Nucleic Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nucleic Vaccine Market Size Markets, 2021 & 2028
4.1.2 Preventive Nucleic Vaccine
4.1.3 Therapeutic Nucleic Vaccine
4.2 By Type - Global Nucleic Vaccine Revenue & Forecasts
4.2.1 By Type - Global Nucleic Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Nucleic Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Nucleic Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Nucleic Vaccine Sales & Forecasts
4.3.1 By Type - Global Nucleic Vaccine Sales, 2017-2022
4.3.2 By Type - Global Nucleic Vaccine Sales, 2023-2028
4.3.3 By Type - Global Nucleic Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Nucleic Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nucleic Vaccine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Nucleic Vaccine Revenue & Forecasts
5.2.1 By Application - Global Nucleic Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Nucleic Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Nucleic Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Nucleic Vaccine Sales & Forecasts
5.3.1 By Application - Global Nucleic Vaccine Sales, 2017-2022
5.3.2 By Application - Global Nucleic Vaccine Sales, 2023-2028
5.3.3 By Application - Global Nucleic Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Nucleic Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Nucleic Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Nucleic Vaccine Revenue & Forecasts
6.2.1 By Region - Global Nucleic Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Nucleic Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Nucleic Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Nucleic Vaccine Sales & Forecasts
6.3.1 By Region - Global Nucleic Vaccine Sales, 2017-2022
6.3.2 By Region - Global Nucleic Vaccine Sales, 2023-2028
6.3.3 By Region - Global Nucleic Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Nucleic Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Nucleic Vaccine Sales, 2017-2028
6.4.3 US Nucleic Vaccine Market Size, 2017-2028
6.4.4 Canada Nucleic Vaccine Market Size, 2017-2028
6.4.5 Mexico Nucleic Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Nucleic Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Nucleic Vaccine Sales, 2017-2028
6.5.3 Germany Nucleic Vaccine Market Size, 2017-2028
6.5.4 France Nucleic Vaccine Market Size, 2017-2028
6.5.5 U.K. Nucleic Vaccine Market Size, 2017-2028
6.5.6 Italy Nucleic Vaccine Market Size, 2017-2028
6.5.7 Russia Nucleic Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Nucleic Vaccine Market Size, 2017-2028
6.5.9 Benelux Nucleic Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Nucleic Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Nucleic Vaccine Sales, 2017-2028
6.6.3 China Nucleic Vaccine Market Size, 2017-2028
6.6.4 Japan Nucleic Vaccine Market Size, 2017-2028
6.6.5 South Korea Nucleic Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Nucleic Vaccine Market Size, 2017-2028
6.6.7 India Nucleic Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Nucleic Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Nucleic Vaccine Sales, 2017-2028
6.7.3 Brazil Nucleic Vaccine Market Size, 2017-2028
6.7.4 Argentina Nucleic Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nucleic Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Nucleic Vaccine Sales, 2017-2028
6.8.3 Turkey Nucleic Vaccine Market Size, 2017-2028
6.8.4 Israel Nucleic Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Nucleic Vaccine Market Size, 2017-2028
6.8.6 UAE Nucleic Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Moderna
7.1.1 Moderna Corporate Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna Nucleic Vaccine Major Product Offerings
7.1.4 Moderna Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Moderna Key News
7.2 CureVac
7.2.1 CureVac Corporate Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac Nucleic Vaccine Major Product Offerings
7.2.4 CureVac Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CureVac Key News
7.3 Inovio
7.3.1 Inovio Corporate Summary
7.3.2 Inovio Business Overview
7.3.3 Inovio Nucleic Vaccine Major Product Offerings
7.3.4 Inovio Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Inovio Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Nucleic Vaccine Major Product Offerings
7.4.4 Sanofi Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 GSK
7.5.1 GSK Corporate Summary
7.5.2 GSK Business Overview
7.5.3 GSK Nucleic Vaccine Major Product Offerings
7.5.4 GSK Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 GSK Key News
7.6 CNBG
7.6.1 CNBG Corporate Summary
7.6.2 CNBG Business Overview
7.6.3 CNBG Nucleic Vaccine Major Product Offerings
7.6.4 CNBG Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 CNBG Key News
7.7 Hualan Bio
7.7.1 Hualan Bio Corporate Summary
7.7.2 Hualan Bio Business Overview
7.7.3 Hualan Bio Nucleic Vaccine Major Product Offerings
7.7.4 Hualan Bio Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Hualan Bio Key News
7.8 Zhifei Shengwu
7.8.1 Zhifei Shengwu Corporate Summary
7.8.2 Zhifei Shengwu Business Overview
7.8.3 Zhifei Shengwu Nucleic Vaccine Major Product Offerings
7.8.4 Zhifei Shengwu Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Zhifei Shengwu Key News
7.9 Liaoning Chengda
7.9.1 Liaoning Chengda Corporate Summary
7.9.2 Liaoning Chengda Business Overview
7.9.3 Liaoning Chengda Nucleic Vaccine Major Product Offerings
7.9.4 Liaoning Chengda Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Liaoning Chengda Key News
7.10 BioKangtai
7.10.1 BioKangtai Corporate Summary
7.10.2 BioKangtai Business Overview
7.10.3 BioKangtai Nucleic Vaccine Major Product Offerings
7.10.4 BioKangtai Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 BioKangtai Key News
7.11 CanSinoBIO
7.11.1 CanSinoBIO Corporate Summary
7.11.2 CanSinoBIO Nucleic Vaccine Business Overview
7.11.3 CanSinoBIO Nucleic Vaccine Major Product Offerings
7.11.4 CanSinoBIO Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 CanSinoBIO Key News
7.12 Walvax Biotechnology
7.12.1 Walvax Biotechnology Corporate Summary
7.12.2 Walvax Biotechnology Nucleic Vaccine Business Overview
7.12.3 Walvax Biotechnology Nucleic Vaccine Major Product Offerings
7.12.4 Walvax Biotechnology Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Walvax Biotechnology Key News
7.13 Fosun Pharma
7.13.1 Fosun Pharma Corporate Summary
7.13.2 Fosun Pharma Nucleic Vaccine Business Overview
7.13.3 Fosun Pharma Nucleic Vaccine Major Product Offerings
7.13.4 Fosun Pharma Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Fosun Pharma Key News
8 GLOBAL NUCLEIC VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nucleic Vaccine Production Capacity, 2017-2028
8.2 Nucleic Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Nucleic Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NUCLEIC VACCINE SUPPLY CHAIN ANALYSIS
10.1 Nucleic Vaccine Industry Value Chain
10.2 Nucleic Vaccine Upstream Market
10.3 Nucleic Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nucleic Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Nucleic Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL NUCLEIC VACCINE OVERALL MARKET SIZE
2.1 Global Nucleic Vaccine Market Size: 2021 VS 2028
2.2 Global Nucleic Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nucleic Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Nucleic Vaccine Players in Global Market
3.2 Top Global Nucleic Vaccine Companies Ranked by Revenue
3.3 Global Nucleic Vaccine Revenue by Companies
3.4 Global Nucleic Vaccine Sales by Companies
3.5 Global Nucleic Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nucleic Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nucleic Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nucleic Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Nucleic Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Nucleic Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Nucleic Vaccine Market Size Markets, 2021 & 2028
4.1.2 Preventive Nucleic Vaccine
4.1.3 Therapeutic Nucleic Vaccine
4.2 By Type - Global Nucleic Vaccine Revenue & Forecasts
4.2.1 By Type - Global Nucleic Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Nucleic Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Nucleic Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Nucleic Vaccine Sales & Forecasts
4.3.1 By Type - Global Nucleic Vaccine Sales, 2017-2022
4.3.2 By Type - Global Nucleic Vaccine Sales, 2023-2028
4.3.3 By Type - Global Nucleic Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Nucleic Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Nucleic Vaccine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Nucleic Vaccine Revenue & Forecasts
5.2.1 By Application - Global Nucleic Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Nucleic Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Nucleic Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Nucleic Vaccine Sales & Forecasts
5.3.1 By Application - Global Nucleic Vaccine Sales, 2017-2022
5.3.2 By Application - Global Nucleic Vaccine Sales, 2023-2028
5.3.3 By Application - Global Nucleic Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Nucleic Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Nucleic Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Nucleic Vaccine Revenue & Forecasts
6.2.1 By Region - Global Nucleic Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Nucleic Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Nucleic Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Nucleic Vaccine Sales & Forecasts
6.3.1 By Region - Global Nucleic Vaccine Sales, 2017-2022
6.3.2 By Region - Global Nucleic Vaccine Sales, 2023-2028
6.3.3 By Region - Global Nucleic Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Nucleic Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Nucleic Vaccine Sales, 2017-2028
6.4.3 US Nucleic Vaccine Market Size, 2017-2028
6.4.4 Canada Nucleic Vaccine Market Size, 2017-2028
6.4.5 Mexico Nucleic Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Nucleic Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Nucleic Vaccine Sales, 2017-2028
6.5.3 Germany Nucleic Vaccine Market Size, 2017-2028
6.5.4 France Nucleic Vaccine Market Size, 2017-2028
6.5.5 U.K. Nucleic Vaccine Market Size, 2017-2028
6.5.6 Italy Nucleic Vaccine Market Size, 2017-2028
6.5.7 Russia Nucleic Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Nucleic Vaccine Market Size, 2017-2028
6.5.9 Benelux Nucleic Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Nucleic Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Nucleic Vaccine Sales, 2017-2028
6.6.3 China Nucleic Vaccine Market Size, 2017-2028
6.6.4 Japan Nucleic Vaccine Market Size, 2017-2028
6.6.5 South Korea Nucleic Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Nucleic Vaccine Market Size, 2017-2028
6.6.7 India Nucleic Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Nucleic Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Nucleic Vaccine Sales, 2017-2028
6.7.3 Brazil Nucleic Vaccine Market Size, 2017-2028
6.7.4 Argentina Nucleic Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Nucleic Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Nucleic Vaccine Sales, 2017-2028
6.8.3 Turkey Nucleic Vaccine Market Size, 2017-2028
6.8.4 Israel Nucleic Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Nucleic Vaccine Market Size, 2017-2028
6.8.6 UAE Nucleic Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Moderna
7.1.1 Moderna Corporate Summary
7.1.2 Moderna Business Overview
7.1.3 Moderna Nucleic Vaccine Major Product Offerings
7.1.4 Moderna Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Moderna Key News
7.2 CureVac
7.2.1 CureVac Corporate Summary
7.2.2 CureVac Business Overview
7.2.3 CureVac Nucleic Vaccine Major Product Offerings
7.2.4 CureVac Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 CureVac Key News
7.3 Inovio
7.3.1 Inovio Corporate Summary
7.3.2 Inovio Business Overview
7.3.3 Inovio Nucleic Vaccine Major Product Offerings
7.3.4 Inovio Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Inovio Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Nucleic Vaccine Major Product Offerings
7.4.4 Sanofi Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 GSK
7.5.1 GSK Corporate Summary
7.5.2 GSK Business Overview
7.5.3 GSK Nucleic Vaccine Major Product Offerings
7.5.4 GSK Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 GSK Key News
7.6 CNBG
7.6.1 CNBG Corporate Summary
7.6.2 CNBG Business Overview
7.6.3 CNBG Nucleic Vaccine Major Product Offerings
7.6.4 CNBG Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 CNBG Key News
7.7 Hualan Bio
7.7.1 Hualan Bio Corporate Summary
7.7.2 Hualan Bio Business Overview
7.7.3 Hualan Bio Nucleic Vaccine Major Product Offerings
7.7.4 Hualan Bio Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Hualan Bio Key News
7.8 Zhifei Shengwu
7.8.1 Zhifei Shengwu Corporate Summary
7.8.2 Zhifei Shengwu Business Overview
7.8.3 Zhifei Shengwu Nucleic Vaccine Major Product Offerings
7.8.4 Zhifei Shengwu Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Zhifei Shengwu Key News
7.9 Liaoning Chengda
7.9.1 Liaoning Chengda Corporate Summary
7.9.2 Liaoning Chengda Business Overview
7.9.3 Liaoning Chengda Nucleic Vaccine Major Product Offerings
7.9.4 Liaoning Chengda Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Liaoning Chengda Key News
7.10 BioKangtai
7.10.1 BioKangtai Corporate Summary
7.10.2 BioKangtai Business Overview
7.10.3 BioKangtai Nucleic Vaccine Major Product Offerings
7.10.4 BioKangtai Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 BioKangtai Key News
7.11 CanSinoBIO
7.11.1 CanSinoBIO Corporate Summary
7.11.2 CanSinoBIO Nucleic Vaccine Business Overview
7.11.3 CanSinoBIO Nucleic Vaccine Major Product Offerings
7.11.4 CanSinoBIO Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 CanSinoBIO Key News
7.12 Walvax Biotechnology
7.12.1 Walvax Biotechnology Corporate Summary
7.12.2 Walvax Biotechnology Nucleic Vaccine Business Overview
7.12.3 Walvax Biotechnology Nucleic Vaccine Major Product Offerings
7.12.4 Walvax Biotechnology Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Walvax Biotechnology Key News
7.13 Fosun Pharma
7.13.1 Fosun Pharma Corporate Summary
7.13.2 Fosun Pharma Nucleic Vaccine Business Overview
7.13.3 Fosun Pharma Nucleic Vaccine Major Product Offerings
7.13.4 Fosun Pharma Nucleic Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Fosun Pharma Key News
8 GLOBAL NUCLEIC VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Nucleic Vaccine Production Capacity, 2017-2028
8.2 Nucleic Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Nucleic Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 NUCLEIC VACCINE SUPPLY CHAIN ANALYSIS
10.1 Nucleic Vaccine Industry Value Chain
10.2 Nucleic Vaccine Upstream Market
10.3 Nucleic Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Nucleic Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Nucleic Vaccine in Global Market
Table 2. Top Nucleic Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nucleic Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nucleic Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Nucleic Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Nucleic Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nucleic Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Nucleic Vaccine Product Type
Table 9. List of Global Tier 1 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nucleic Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nucleic Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nucleic Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nucleic Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Nucleic Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Nucleic Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nucleic Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nucleic Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nucleic Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Nucleic Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Nucleic Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nucleic Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nucleic Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nucleic Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Nucleic Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nucleic Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Nucleic Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nucleic Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Nucleic Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nucleic Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Nucleic Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nucleic Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Nucleic Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nucleic Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Nucleic Vaccine Sales, (K Units), 2023-2028
Table 46. Moderna Corporate Summary
Table 47. Moderna Nucleic Vaccine Product Offerings
Table 48. Moderna Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CureVac Corporate Summary
Table 50. CureVac Nucleic Vaccine Product Offerings
Table 51. CureVac Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Inovio Corporate Summary
Table 53. Inovio Nucleic Vaccine Product Offerings
Table 54. Inovio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Nucleic Vaccine Product Offerings
Table 57. Sanofi Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GSK Corporate Summary
Table 59. GSK Nucleic Vaccine Product Offerings
Table 60. GSK Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. CNBG Corporate Summary
Table 62. CNBG Nucleic Vaccine Product Offerings
Table 63. CNBG Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Hualan Bio Corporate Summary
Table 65. Hualan Bio Nucleic Vaccine Product Offerings
Table 66. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Zhifei Shengwu Corporate Summary
Table 68. Zhifei Shengwu Nucleic Vaccine Product Offerings
Table 69. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Liaoning Chengda Corporate Summary
Table 71. Liaoning Chengda Nucleic Vaccine Product Offerings
Table 72. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. BioKangtai Corporate Summary
Table 74. BioKangtai Nucleic Vaccine Product Offerings
Table 75. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. CanSinoBIO Corporate Summary
Table 77. CanSinoBIO Nucleic Vaccine Product Offerings
Table 78. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Walvax Biotechnology Corporate Summary
Table 80. Walvax Biotechnology Nucleic Vaccine Product Offerings
Table 81. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Fosun Pharma Corporate Summary
Table 83. Fosun Pharma Nucleic Vaccine Product Offerings
Table 84. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Nucleic Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Nucleic Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Nucleic Vaccine Production by Region, 2017-2022 (K Units)
Table 88. Global Nucleic Vaccine Production by Region, 2023-2028 (K Units)
Table 89. Nucleic Vaccine Market Opportunities & Trends in Global Market
Table 90. Nucleic Vaccine Market Drivers in Global Market
Table 91. Nucleic Vaccine Market Restraints in Global Market
Table 92. Nucleic Vaccine Raw Materials
Table 93. Nucleic Vaccine Raw Materials Suppliers in Global Market
Table 94. Typical Nucleic Vaccine Downstream
Table 95. Nucleic Vaccine Downstream Clients in Global Market
Table 96. Nucleic Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Nucleic Vaccine in Global Market
Table 2. Top Nucleic Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nucleic Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nucleic Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Nucleic Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Nucleic Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nucleic Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Nucleic Vaccine Product Type
Table 9. List of Global Tier 1 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nucleic Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nucleic Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nucleic Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nucleic Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Nucleic Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Nucleic Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nucleic Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nucleic Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nucleic Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Nucleic Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Nucleic Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nucleic Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nucleic Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nucleic Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Nucleic Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nucleic Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Nucleic Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nucleic Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Nucleic Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nucleic Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Nucleic Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nucleic Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Nucleic Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Nucleic Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nucleic Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nucleic Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Nucleic Vaccine Sales, (K Units), 2023-2028
Table 46. Moderna Corporate Summary
Table 47. Moderna Nucleic Vaccine Product Offerings
Table 48. Moderna Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. CureVac Corporate Summary
Table 50. CureVac Nucleic Vaccine Product Offerings
Table 51. CureVac Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Inovio Corporate Summary
Table 53. Inovio Nucleic Vaccine Product Offerings
Table 54. Inovio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Sanofi Corporate Summary
Table 56. Sanofi Nucleic Vaccine Product Offerings
Table 57. Sanofi Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. GSK Corporate Summary
Table 59. GSK Nucleic Vaccine Product Offerings
Table 60. GSK Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. CNBG Corporate Summary
Table 62. CNBG Nucleic Vaccine Product Offerings
Table 63. CNBG Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Hualan Bio Corporate Summary
Table 65. Hualan Bio Nucleic Vaccine Product Offerings
Table 66. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Zhifei Shengwu Corporate Summary
Table 68. Zhifei Shengwu Nucleic Vaccine Product Offerings
Table 69. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Liaoning Chengda Corporate Summary
Table 71. Liaoning Chengda Nucleic Vaccine Product Offerings
Table 72. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. BioKangtai Corporate Summary
Table 74. BioKangtai Nucleic Vaccine Product Offerings
Table 75. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. CanSinoBIO Corporate Summary
Table 77. CanSinoBIO Nucleic Vaccine Product Offerings
Table 78. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Walvax Biotechnology Corporate Summary
Table 80. Walvax Biotechnology Nucleic Vaccine Product Offerings
Table 81. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Fosun Pharma Corporate Summary
Table 83. Fosun Pharma Nucleic Vaccine Product Offerings
Table 84. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Nucleic Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 86. Global Nucleic Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Nucleic Vaccine Production by Region, 2017-2022 (K Units)
Table 88. Global Nucleic Vaccine Production by Region, 2023-2028 (K Units)
Table 89. Nucleic Vaccine Market Opportunities & Trends in Global Market
Table 90. Nucleic Vaccine Market Drivers in Global Market
Table 91. Nucleic Vaccine Market Restraints in Global Market
Table 92. Nucleic Vaccine Raw Materials
Table 93. Nucleic Vaccine Raw Materials Suppliers in Global Market
Table 94. Typical Nucleic Vaccine Downstream
Table 95. Nucleic Vaccine Downstream Clients in Global Market
Table 96. Nucleic Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Nucleic Vaccine Segment by Type
Figure 2. Nucleic Vaccine Segment by Application
Figure 3. Global Nucleic Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nucleic Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nucleic Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Nucleic Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nucleic Vaccine Revenue in 2021
Figure 9. By Type - Global Nucleic Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nucleic Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Nucleic Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nucleic Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Nucleic Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nucleic Vaccine Sales Market Share, 2017-2028
Figure 19. US Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nucleic Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nucleic Vaccine Sales Market Share, 2017-2028
Figure 33. China Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nucleic Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nucleic Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nucleic Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Nucleic Vaccine by Region, 2021 VS 2028
Figure 50. Nucleic Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Nucleic Vaccine Segment by Type
Figure 2. Nucleic Vaccine Segment by Application
Figure 3. Global Nucleic Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nucleic Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nucleic Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Nucleic Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nucleic Vaccine Revenue in 2021
Figure 9. By Type - Global Nucleic Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nucleic Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Nucleic Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nucleic Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Nucleic Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nucleic Vaccine Sales Market Share, 2017-2028
Figure 19. US Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nucleic Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nucleic Vaccine Sales Market Share, 2017-2028
Figure 33. China Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nucleic Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nucleic Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nucleic Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nucleic Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nucleic Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Nucleic Vaccine by Region, 2021 VS 2028
Figure 50. Nucleic Vaccine Industry Value Chain
Figure 51. Marketing Channels
